HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N-terminal proatrial natriuretic peptide

released when the 126 amino acid prohormone ANP (atrial natriuretic peptide) is cleaved by a membrane protease: has 98 amino acid residues
Networked: 30 relevant articles (0 outcomes, 7 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Hall, C: 7 articles (07/2002 - 06/2000)
2. Wang, Thomas J: 4 articles (01/2010 - 02/2004)
3. Benjamin, Emelia J: 4 articles (01/2010 - 02/2004)
4. Vasan, Ramachandran S: 4 articles (01/2010 - 02/2004)
5. Levy, Daniel: 4 articles (01/2010 - 02/2004)
6. Larson, Martin G: 4 articles (01/2010 - 02/2004)
7. Hall, Christian: 4 articles (03/2004 - 04/2002)
8. Meigs, James B: 3 articles (01/2010 - 03/2007)
9. Tofler, Geoffrey H: 3 articles (01/2010 - 03/2007)
10. Selhub, Jacob: 3 articles (01/2010 - 03/2007)

Related Diseases

1. Heart Failure
2. Myocardial Infarction
3. Inflammation
08/28/2007 - "We measured 8 circulating biomarkers reflecting inflammation (C-reactive protein), hemostasis (plasminogen activator inhibitor-1, fibrinogen), neurohormonal activity (aldosterone, renin, B-type natriuretic peptide, N-terminal proatrial natriuretic peptide), and endothelial dysfunction (homocysteine) in 2292 Framingham Offspring Study participants (mean age, 57 years; 56% women). "
01/19/2010 - "In 3120 Framingham cohort participants (mean age 58.4+/-9.7 years, 54% women), we related 10 biomarkers that represented inflammation (C-reactive protein and fibrinogen), neurohormonal activation (B-type natriuretic peptide [BNP] and N-terminal proatrial natriuretic peptide), oxidative stress (homocysteine), the renin-angiotensin-aldosterone system (renin and aldosterone), thrombosis and endothelial function (D-dimer and plasminogen activator inhibitor type 1), and microvascular damage (urinary albumin excretion; n=2673) to incident AF (n=209, 40% women) over a median follow-up of 9.7 years (range 0.05 to 12.8 years). "
03/01/2007 - "We prospectively studied 1456 nonhypertensive individuals who had baseline measurement of 9 biomarkers: C-reactive protein (inflammation); fibrinogen (inflammation and thrombosis); plasminogen activator inhibitor-1 (fibrinolytic potential); aldosterone, renin, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide (neurohormonal activity); homocysteine (renal function and oxidant stress); and urinary albumin/creatinine ratio (glomerular endothelial function). "
4. Disease Susceptibility (Diathesis)
5. Heart Diseases (Heart Disease)

Related Drugs and Biologics

1. Brain Natriuretic Peptide (Natrecor)
2. Atrial Natriuretic Factor (ANF)
3. Biological Markers (Surrogate Marker)
4. Renin
5. Homocysteine
6. Fibrinogen (Factor I)
7. C-Reactive Protein
8. Aldosterone
9. Natriuretic Peptides
10. C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)

Related Therapies and Procedures

1. Angioplasty (Angioplasty, Transluminal)
2. Radiotherapy
3. Drug Therapy (Chemotherapy)